Featured Press Releases

Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.

Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

  • 28 Aug 2024

CVS Health® announced that the updated 2024-2025 COVID-19 vaccines and flu vaccines are available...

Samsung Bioepis and Organon’s HADLIMA™ Gains FDA Interchangeability Designation, Expanding Access to Adalimumab Alternative

Samsung Bioepis and Organon’s HADLIMA™ Gains FDA Interchangeability Designation, Expanding Access to Adalimumab Alternative

Setting a New Standard for End-to-End Traceability and Data Integrity, Waters Enhances Alliance iS HPLC System Software.

Setting a New Standard for End-to-End Traceability and Data Integrity, Waters Enhances Alliance iS HPLC System Software.

Cold Box Express, Inc. Introduces Refreshed Brand

Cold Box Express, Inc. Introduces Refreshed Brand

Avenacy announces launch of Eptifibatide for Injection in the U.S.

Avenacy announces launch of Eptifibatide for Injection in the U.S.

Industry Veteran Marie Emms Appointed President of Clinical Business at Spectrum Science

Industry Veteran Marie Emms Appointed President of Clinical Business at Spectrum Science

  • Spectrum Science
  • 08 Jul 2026
Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

  • Omega Laboratories, Inc.
  • 08 Jul 2026
Organon to Present New Analysis of VTAMA® (tapinarof) Cream, 1%

Organon to Present New Analysis of VTAMA® (tapinarof) Cream, 1%

  • Organon
  • 07 Jul 2026
European Commission Approves AbbVie

European Commission Approves AbbVie's TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • AbbVie
  • 06 Jul 2026
Nnamdi Njoku Named President of Omnicell

Nnamdi Njoku Named President of Omnicell

  • Omnicell, Inc.
  • 01 Jul 2026
Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

  • Novo Nordisk
  • 01 Jul 2026
The Digital Pharma Advances Conference 2026

Most Popular
July   2026
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.